Bottom line
How much do IXJ and JDOC overlap?
68% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 58.7% of IXJ's assets and 63.9% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
IXJ holds far more positions (124 vs 61), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IXJ and JDOC have in common
| Holding | % of IXJ | % of JDOC | Overlap |
|---|---|---|---|
| Eli Lilly And Company | 10.93% | 7.76% | 7.76% |
| Johnson & Johnson | 7.04% | 4.82% | 4.82% |
| Abbvie Inc. | 5.12% | 7.85% | 5.12% |
| Unitedhealth Group Incorporated | 4.40% | 5.85% | 4.40% |
| Merck & Co., Inc. | 4.12% | 4.82% | 4.12% |
| Astrazeneca Plc | 3.76% | 3.76% | 3.76% |
| Roche Holding AG | 3.75% | 2.82% | 2.82% |
| Novartis AG | 3.71% | 1.60% | 1.60% |
| Thermo Fisher Scientific Incorporated | 2.42% | 3.73% | 2.42% |
| Abbott Laboratories | 2.05% | 3.11% | 2.05% |
| Novo Nordisk A/s | 1.99% | 2.61% | 1.99% |
| Intuitive Surgical, Inc. | 1.83% | 1.93% | 1.83% |
| Cvs Health Corporation | 1.71% | 2.83% | 1.71% |
| Danaher Corporation | 1.56% | 2.16% | 1.56% |
| Bristol-myers Squibb Company | 1.53% | 3.57% | 1.53% |
| Stryker Corporation | 1.41% | 2.23% | 1.41% |
| Gsk Plc | 1.38% | 2.47% | 1.38% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IXJ
- Amgen Inc. — 2.54%
- Gilead Sciences, Inc. — 2.04%
- Pfizer Inc. — 1.78%
- Vertex Pharmaceuticals Incorporated — 1.64%
- Medtronic Public Limited Company — 1.30%
- Sanofi Sa — 1.18%
- Mckesson Corporation — 1.18%
- Elevance Health, Inc. — 1.09%
Only in JDOC
- Cencora, Inc. — 2.07%
- Argenx SE — 2.06%
- Edwards Lifesciences Corp. — 1.73%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Regeneron Pharmaceuticals, Inc. — 1.60%
- Biogen, Inc. — 1.56%
- Cardinal Health, Inc. — 1.51%
Asset mix
| Asset type | IXJ | JDOC |
|---|---|---|
| Stocks | 99.6% | 99.2% |
| Cash & short-term funds | 1.3% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | IXJ | JDOC |
|---|---|---|
| US | 70.6% | 75.2% |
| CH | 10.4% | 4.4% |
| GB | 5.8% | 6.2% |
| DK | 2.3% | 4.0% |
| JP | 3.7% | 2.5% |
| NL | 1.1% | 2.4% |
| FR | 2.0% | — |
| DE | 1.6% | 1.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IXJ and JDOC overlap?
What stocks do IXJ and JDOC have in common?
Should I own both IXJ and JDOC?
Which holds more stocks, IXJ or JDOC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.